CoronaryAtlas logo
CoronaryAtlas
Paraoxonase 1
Pathway / Lipid retention & oxidation

Paraoxonase 1

PON1protein

PON1 is an HDL-associated esterase that hydrolyzes oxidized phospholipids in LDL, preventing lipid-core accumulation and plaque inflammation.

Pathway placement
Cascade stepLipid retention & oxidation
Confidencehigh
RationaleHDL-resident esterase protecting against LDL oxidation; reduced in ACS.
Also acts inVascular inflammation, Endothelial activation/erosion
Druggability
DruggableYes
Known drugs / candidates0
Small-molecule tractableYes
Antibody tractableYes
EnsemblENSG00000005421

Type I vs Type II discrimination

ScoresLow-confidence (proxy)
R — rupture / Type-I
63
C — confounder / Type-II
66
A — assay feasibility
68
E — evidence strength
27
T1DI (composite)
9
Specificity differential (R−C)-3
Confounder panel (Type-II drivers)
No confounder evidence retrieved.
Tier: light (literature co-occurrence proxy — lower confidence). See the discrimination table for all markers.

Assay & specimen

Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)

Human genetic evidence

0.020
Open Targets association (STEMI)

Literature evidence(9)